Maria Bedoya-Toro Munera
Algemeen Adviseur bij DERMATA THERAPEUTICS, INC.
Vermogen: 2 436 $ op 30-04-2024
Profiel
Maria Bedoya-Toro Munera is currently the Senior VP-Regulatory Affairs & Quality Assurance at Dermata Therapeutics, Inc. She previously held positions at Amylin Pharmaceuticals, Inc., Ligand Pharmaceuticals, Inc., Eisai Medical Research, Inc., Baxter Hyland Immuno, BASF Bioresearch Corp., Santarus, Inc., and Receptos LLC.
Bedoya-Toro Munera has an MBA from The University of Chicago, a doctorate from The Ohio University, and undergraduate and graduate degrees from Western Michigan University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 04-01-2024 | 7 164 ( 0.11% ) | 2 436 $ | 30-04-2024 |
Actieve functies van Maria Bedoya-Toro Munera
| Bedrijven | Functie | Begin |
|---|---|---|
| DERMATA THERAPEUTICS, INC. | Algemeen Adviseur | 01-01-2016 |
Eerdere bekende functies van Maria Bedoya-Toro Munera
| Bedrijven | Functie | Einde |
|---|---|---|
| RECEPTOS INC | Algemeen Adviseur | 01-01-2015 |
Santarus, Inc.
 Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ. | Algemeen Adviseur | 02-01-2014 |
| Eisai Medical Research, Inc. | Algemeen Adviseur | 01-05-2007 |
| LIGAND PHARMACEUTICALS INCORPORATED | Algemeen Adviseur | 01-01-2006 |
| Baxter Hyland Immuno | Algemeen Adviseur | 01-01-2003 |
Opleiding van Maria Bedoya-Toro Munera
| The University of Chicago | Masters Business Admin |
| The Ohio University | Doctorate Degree |
| Western Michigan University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| DERMATA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
Santarus, Inc.
Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ. | Health Technology |
| Eisai Medical Research, Inc. | |
| Baxter Hyland Immuno | |
| BASF Bioresearch Corp. | |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Receptos LLC engages in the provision of developing and commercializing of therapeutic candidates for the treatment of immune and inflammatory diseases. It offers Ozanimod for relapsing multiple sclerosis, Ozanimod for inflammatory bowel disease and RPC4046 for eosinophilic esophagitis. The company was founded by Marcus F. Boehm, Robert J. Peach, William H. Rastetter, Hugh Rosen and Raymond C. Stevens on September 26, 2008 and is headquartered in San Diego, CA. | Health Technology |
